Draft:Anand Reddi

  • Comment: Thank you @SafariScribe and @CFA for the excellent feedback and very thoughtful responses to improve the article. 1. The references have been improved including notable 3rd party new sources since the initial submission per @SafariScribe. 2. The draft has been significantly re-written to reflect the editorial comments from @CFA on encyclopedic quality as well as past comments on the deletion comments posted by CFA that existed on the Wikipedia page that was live from 2012-2024. The provision of antiretroviral therapy in the resource limited settings of Africa is extremly important topic as the donor community recommits funding for HIV scale-up in Africa as well as pandemic preparedness. The work of this subject matter expert is important to profile given the current debates. 💬 17:47, 16 August 2024 (UTC)

Anand Reddi
Born
Maryland, USA
NationalityAmerican
EducationUniversity of Michigan, Ann Arbor, University of Colorado School of Medicine
Occupation(s)Global Health Policy Advocate, Public Health Specialist, Biotech Executive
Known forAdvocacy in global HIV/AIDS treatment and health systems strengthening
AwardsFulbright Scholar, American Medical Association Foundation Leadership Award

Anand Reddi is a health system strengthening expert, global health specialist and public health advocate. His early work focused on global HIV scale-up including the President's Emergency Plan for AIDS Relief (PEPFAR).[1][2][3][4][5][6][7] Since 2015, Reddi works in the biotech industry advancing access to essential medicines and building global public-private health partnerships.[8][9][10][11] He served on several global health not-for-profit board of directors including the AIDS Healthcare Foundation and the Bay Area Global Health Alliance.[12]

  1. ^ Cite error: The named reference :2 was invoked but never defined (see the help page).
  2. ^ Cite error: The named reference :3 was invoked but never defined (see the help page).
  3. ^ Liu, Richard (19 November 2020). "Atlantic Dialogues Talks 2020: Health Capacities as a New Power Instrument". The Atlantic Dialogues: Policy Center for the New South.
  4. ^ Purvis, Katherine. "How do we increase the HIV response with limited funds?". The Guardian. Retrieved 6 July 2024.
  5. ^ Banning-Lover, Rachel. "What is the best model to bring healthcare to all?". The Guardian. Retrieved 19 June 2024.
  6. ^ Mungcal, Ivy (18 October 2011). "Anand Reddi: PEPFAR at Risk Should Mitt Romney Become US President". Devex.
  7. ^ Judem, Emily. "An invisible issue: The presidential campaign and HIV/AIDS". The World Radio Program.
  8. ^ "Pharma companies are capitalizing on Covid-19 restrictions to promote unbranded campaigns". Pharmaceutical Technology Review. Retrieved 23 July 2024.
  9. ^ Bulik, Beth Snyder (28 Oct 2020). "BI, Gilead execs highlight value of disease awareness campaigns—particularly during the pandemic". Fierce Pharma.
  10. ^ "Adverum Announces Senior Appointments for Patient Access and Clinical Operations as ADVM-022 Advances Toward Global Phase 3 Trials". The Globe and Mail. 30 March 2021.
  11. ^ "Hepion Pharmaceuticals Further Strengthens Board with Appointments of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi and Dr. Kaouthar Lbiati". NASDAQ. 28 June 2022.
  12. ^ "Speaking out on Social/Political issues: CHRO's role in working with CEO". HR Strategy Forum. Retrieved 8 July 2024.